ArticleHealth science reports2026
Predicting Prostate Cancer Risk and Its Associated Factors Using Machine Learning Techniques: A Retrospective Study.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Prostate cancer affects many people around the world and is fatal. Today, artificial intelligence-based techniques are widely used to predict and diagnose diseases. This study aimed to use machine learning-based techniques to predict and identify the most significant risk factors of prostate cancer. Methods: This retrospective study was conducted at the Shahid Beheshti Hospital, Hamadan Province, Iran, in five steps, including the identification of risk factors, data collection, preprocessing, modeling, and evaluation. The Web of Science, Scopus, Medline, and PubMed Central databases were searched from the beginning of 2000 to 2024. Different prediction algorithms, including Logistic Regression, Gradient Boosting, Random Forest, XGBoost, Support Vector Machine, and Neural Networks algorithms developed based on 49 confirmed factors. 597 medical records were reviewed. 342 patients (57.29%) had prostate cancer, and 255 patients (42.71%) had benign prostate hyperplasia. The algorithm's performance was evaluated using accuracy, precision, recall, F1-score, and support metrics. Results: The results of this study showed the XG Boosting model performed best in predicting the effective factors, with an accuracy of 77.5% a sensitivity of 74.5%, and a specificity of 79.7%. Key predictors included total and free prostate-specific antigen (PSA) levels, hemoglobin, BMI, and fish consumption. Conclusion: Machine learning can enhance and personalize the identification of potential risks of PCa, but more research is necessary to refine these algorithms and address data biases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.